Osteoporosis during Pregnancy - Case Report and Review


Osteoporosis; pregnancy; fracture, bone mineral density; DEXA.

How to Cite

Gashi, A., Ismajli, J., Berisha, I., Elshani, B., Rraci, B. and Berisha, A. 2021. Osteoporosis during Pregnancy - Case Report and Review. Rheumatology (Bulgaria). 29, 2 (Jul. 2021), 85-90. DOI:https://doi.org/10.35465/29.2.2021.pp85-90.


Osteoporosis is a condition that rarely occurs during pregnancy, but due to loss of bone density, bones become fragile and may suffer fractures. During pregnancy, the aetiology of osteoporosis is unknown. But there are a large number of identifiable risk factors that can influence the development of osteoporosis. Generally, symptoms and signs most often begin in the third trimester of the first pregnancy and improve after delivery, as they do not usually recur in subsequent pregnancies. To diagnose osteoporosis, as well as to determine the risk of fractures and follow-up medication are used bone mineral density (BMD) measurement and determination of the level of the final products (biomarkers), which are released during bone degradation and formation. The dual-energy X-ray absorptiometry (DEXA) is the leading technique for estimating bone mineral density. So far there is no specific treatment for osteoporosis during pregnancy. In many cases, the adverse effects of osteoporosis are reversible with appropriate and timely intervention. Therefore, treatment with calcium and vitamin D supplements during pregnancy in women who have two or more risk factors for developing osteoporosis may be reasonable.



  1. Shea B, Wells G, Cranney A, Zytaruk N, Robinson V, Griffith L, Ortiz Z, Peterson J, Adachi J, Tugwell P, Guyatt G. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocrine Reviews. 2002 Aug 1;23(4):552-9.
  2. Shea BJ, Adachi JD, Cranney A, Griffith L, Guyatt G, Hamel C, Ortiz Z, Peterson J, Robinson VA, Tugwell P, Wells G. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database of Systematic Reviews. 2004(1).
  3. Xu L, McElduff P, D'Este C, Attia J. Does dietary calcium have a protective effect on bone fractures in women? A meta-analysis of observational studies. British journal of nutrition. 2004 Apr; 91(4):625-34.
  4. Wallace BA, Cumming RG. Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women. Calcified Tissue International. 2000 Jul 1;67(1):10-8.
  5. Cauley JA. Public health impact of osteoporosis. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2013 Oct 1;68(10):1243-51.
  6. Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, Black DM. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women: a prospective study. Archives of internal medicine. 1997 Mar 24; 157(6):629-34.
  7. Cauley JA. Defining ethnic and racial differences in osteoporosis and fragility fractures. Clinical Orthopaedics and Related Research®. 2011 Jul 1; 469(7):1891.
  8. Van der Sluis IM, De Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Archives of disease in childhood. 2002 Oct 1;87(4):341-7.
  9. Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA. Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. Journal of Clinical Densitometry. 2011 Jul 1; 14(3):302-12.
  10. Garg MK, Kharb S. Dual energy X-ray absorptiometry: Pitfalls in measurement and interpretation of bone mineral density. Indian journal of endocrinology and metabolism. 2013 Mar; 17(2):203.
  11. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. Journal of translational medicine. 2013 Dec 1; 11(1):201.
  12. Swaminathan R. Biochemical markers of bone turnover. Clinica chimica acta. 2001 Nov 1; 313(1-2):95-105.
  13. Weaver CM, Peacock M, Martin BR, McCabe GP, Zhao J, Smith DL, Wastney ME. Quantification of biochemical markers of bone turnover by kinetic measures of bone formation and resorption in young healthy females. Journal of Bone and Mineral Research. 1997 Oct; 12(10):1714-20.
  14. Välimäki MJ, Tähtelä R, Jones JD, Peterson JM, Riggs BL. Bone resorption in healthy and osteoporotic postmenopausal women: comparison markers for serum carboxy-terminal telopeptide of type I collagen and urinary pyridinium cross-links. European journal of endocrinology. 1994 Sep 1; 131(3):258-62.
  15. Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus—a systematic review. Bone. 2016 Jan 1; 82:69-78.
  16. Ismail F. To Study the Regulation of Bone Markers in Osteoporosis (Doctoral dissertation, Aligarh Muslim University).
  17. Delmas PD. Biochemical markers of bone turnover for the clinical investigation of osteoporosis. Osteoporosis International. 1993 Jan 1; 3(1):81-6.
  18. Takeuchi SI, Arai K, Saitoh H, Yoshida KI, Miura M. Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. The Journal of urology. 1996 Nov 1; 156(5):1691-5.
  19. Fardellone P, Brazier M, Kamel S, Guéris J, Graulet AM, Liénard J, Sebert JL. Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. The American journal of clinical nutrition. 1998 Jun 1; 67(6):1273-8.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.